Figure_2.tif (148.13 kB)

Duration and intensity of systemic reactogenicity.

Download (0 kB)
posted on 27.10.2010, 00:35 by Laurence Peiperl, Cecilia Morgan, Zoe Moodie, Hongli Li, Nina Russell, Barney S. Graham, Georgia D. Tomaras, Stephen C. De Rosa, M. Juliana McElrath

Number of vaccine recipients experiencing each level of severity in one or more systemic symptoms (malaise and/or fatigue, myalgia, headache, nausea, vomiting, chills, or arthralgia) is shown at baseline and for each day of the reactogenicity period. Panel A: 1010 PU dose; Panel B: 1011 PU dose. Only the most severe symptom level for each individual on each day is included.